4-Chlorotestosterone acetate NEW
Price | $28 | $25 | $23 |
Package | 1box | 50box | 100box |
Min. Order: | 1box |
Supply Ability: | 20000 |
Update Time: | 2024-06-05 |
Product Details
Product Name: 4-Chlorotestosterone acetate | CAS No.: 855-19-6 |
EC-No.: 212-720-4 | Min. Order: 1box |
Purity: 99% | Supply Ability: 20000 |
Release date: 2024/06/05 |
Melting point :228-230°
Specific rotation :D +118 ±4° (CHCl3)
Boiling point :457.2±45.0 °C(Predicted)
Density :1.19± 0.1g /cm3(Predicted)
Storage conditions :2-8°C
Company Profile Introduction
Shanghai Getian Industrial Co.,Ltd is a leading enterprise committed to providing quality products and efficient logistics services. We are proud to introduce a range of products with excellent quality, and the industrial materials are subject to strict quality control to ensure that the high standards of our customers are met.
We have pharmaceutical raw material production factory and reagent research and development center. We now have a complete product line. In addition, we have developed and produced tens of thousands of reagents. We are complemented by a custom synthesis business of various organic compounds. We can synthesize almost any chemical.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$20.00/1Box |
VIP1Y
|
zhuzhou dingcheng meihei comestic co.,ltd
|
2024-05-30 | |
$1.00/1kg |
VIP4Y
|
Dorne Chemical Technology co. LTD
|
2024-03-26 | |
$0.00/1kg |
VIP1Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2024-01-25 | |
$10.00/1kg |
VIP1Y
|
Wuhan Xinhao Biotechnology Co., Ltd
|
2024-01-17 | |
$0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2023-09-11 | |
$90.00/1kg |
Anhui Zhongda Biotechnology Co., Ltd
|
2023-08-23 | ||
$30.00/1kg |
Anhui Ruihan Technology Co., Ltd
|
2023-08-17 | ||
$0.00/1kg |
Anhui Zhongda Biotechnology Co., Ltd
|
2023-08-03 | ||
$1750.00/100g |
qingdao future trading Co., Ltd
|
2023-06-19 | ||
$1.00/1bottle |
Doublewin Biological Technology Co., Ltd
|
2023-06-15 |
- Since: 2024-01-19
- Address: Hong Kong
INQUIRY